This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Miltenyi Biotec B.v. Co., Kg. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: Jolanda De Vries: Innovator in Cancer Treatment
Introduction
Jolanda De Vries is a prominent inventor based in Nijmegen, Netherlands. She has made significant contributions to the field of cancer treatment through her innovative research and inventions. With a total of 2 patents, her work focuses on developing cell populations that can be utilized in therapeutic applications for cancer patients.
Latest Patents
One of her latest patents involves a cell population for use in treating cancer. This invention pertains to a specific type of cell population comprising CD1c (BDCA-1)/CD19 dendritic cells. The innovation emphasizes the depletion of CD1c (BDCA-1)/CD19/CD14 cells to enhance the efficacy of the treatment. This approach aims to improve patient outcomes in cancer therapy.
Career Highlights
Jolanda De Vries is associated with Miltenyi Biotec B.V. Co., Kg, where she continues to advance her research in cancer treatment. Her work is characterized by a commitment to developing effective therapeutic strategies that can make a difference in the lives of patients battling cancer.
Collaborations
Some of her notable coworkers include Carl Gustav Figdor and Ghaith Bakdash. Their collaborative efforts contribute to the innovative research environment that fosters advancements in cancer treatment.
Conclusion
Jolanda De Vries stands out as a dedicated inventor in the field of cancer therapy. Her innovative patents and collaborative work reflect her commitment to improving treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile